The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the science - and culture - of weight loss. Now a growing body of research is raising ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

The arrival of summer means beach season is calling for many, which may lead some to chase the perfect swimsuit physique. A 2025 Gallup poll showed that 52% of Americans want to lose weight but that ...

June 3 (Reuters) - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than two dozen ...

You’ve probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss and diabetes. Now, researchers are investigating whether these medications ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Lung cancer is among the conditions that may be affected. GLP-1 medications such as Wegovy, ...

Weight-loss and diabetes drugs such as Ozempic, Wegovy and Zepbound may do more than help patients manage blood sugar and obesity, according to new research led by the Cleveland Clinic. The study, ...

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting. Limited time: ...

GLP-1s have shaken up treatment for weight loss with close to 1 in 5 Americans saying they have taken them at some point. Recently, experts shifted attention to the drugs’ effects on the brain. They ...

The use of GLP-1 medications for weight loss continues to rise. One drawback associated with GLP-1 medications is that weight loss not only includes fat loss, but muscle loss as well. A new study ...